Pharmaceutical nanotechnology experts are specialized scientists and researchers who focus on applying nanotechnology principles to the field of drug development and delivery. These experts leverage the unique properties of materials at the nanoscale—typically between 1 to 100 nanometers—to create innovative drug formulations that improve therapeutic efficacy, targeting, and patient compliance. Their work often involves designing nanoparticles, liposomes, nanoemulsions, and other nanocarriers that can enhance drug solubility, stability, and controlled release. By manipulating materials at such a minute scale, pharmaceutical nanotechnology experts enable drugs to cross biological barriers more effectively, reduce side effects by targeting specific tissues or cells, and develop novel treatment options for complex diseases such as cancer, neurological disorders, and infectious diseases.
The role of pharmaceutical nanotechnology experts extends beyond formulation development; they are also deeply involved in characterizing nanomaterials, assessing their safety and biocompatibility, and navigating regulatory pathways for novel nanomedicines. Their expertise requires interdisciplinary knowledge in pharmaceutics, materials science, molecular biology, and toxicology. As nanotechnology continues to revolutionize the pharmaceutical industry, these professionals play a crucial role in translating laboratory discoveries into clinically viable therapies. Their contributions not only pave the way for personalized medicine but also improve drug delivery efficiency, minimize toxicity, and ultimately enhance patient outcomes in modern healthcare.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada